Recombinant CD74 (Milatuzumab Biosimilar) antibody
Quick Overview for Recombinant CD74 (Milatuzumab Biosimilar) antibody (ABIN7581310)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Expression System
 - CHO Cells
 - 
                                            
Purpose
 - Anti-CD74 Reference Antibody (milatuzumab)
 - 
                                            
Sequence
 - QVQLQQSGSE LKKPGASVKV SCKASGYTFT NYGVNWIKQA PGQGLQWMGW INPNTGEPTF DDDFKGRFAF SLDTSVSTAY LQISSLKADD TAVYFCSRSR GKNEAWFAYW GQGTLVTVSS ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPGK ,DIQLTQSPLS LPVTLGQPAS ISCRSSQSLV HRNGNTYLHW FQQRPGQSPR LLIYTVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YFCSQSSHVP PTFGAGTRLE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
 - 
                                            
Characteristics
 - Anti-CD74 Reference Antibody (milatuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
 - 
                                            
Purity
 - >95 %
 - 
                                            
Isotype
 - IgG1
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Comment
 - 
                        
Therapeutic Agents by Target and Mechanism: CD74 inhibitors
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Concentration
 - 1 mg/mL
 - 
                                            
Buffer
 - 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
 - 
                                            
Storage
 - 4 °C,-80 °C
 - 
                                            
Storage Comment
 - +4°C,-80°C
 
 - 
                                            
 - 
    
- CD74 (Milatuzumab Biosimilar)
 - 
                                            
Target Type
 - Biosimilar
 - 
                                            
Molecular Weight
 - 145.5 kDa
 - 
                                            
UniProt
 - P04233
 
Target
 -